References
- Nomenjanahary Rodrigue Emile Hasiniatsy, Leontine Rabarijaona, Florine Rafaramino. Evolution des aspects épidémiologique de cancer du col utérin dans le service oncologie d'Antananarivo, Madagascar. J Afr Cancer. 2011 Feb; 3(1): 3-7. PubMed | Google Scholar
- Ngomo KMJ, Belemembaogo E, Nzenze JR, Meye JF, Diallo
I, Moung. Evaluation de la prise en charge des cancers
du col de l'utérus
par télé-cobalt au Centre Hospitalier de Libreville. Med Afr Noire. 2004
Nov; 5111: 579-584.. PubMed | Google
Scholar
- Wong L C, Choo Y C, Choy D. Long term follow up of potentation of radiotherapy by platinium in advanced cervical cancer. Gynecol Oncol. 1989 Nov;35(2):159-63. PubMed | Google Scholar
- Choo YC, Choy TK, Wong LC, Ma HK. Potentiation of radiotherapy by cis dichlorodiammine platinum (II) in advanced cervical carcinoma. Gynecol Oncol. 1986 ; 23 : 94-100. PubMed | Google Scholar
- Tseng CJ, Chang CT, Lai CH, Soong YK, Hong JH, Tang SG, et al. A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix. Gynecol Oncol. 1997; 66: 52-8. PubMed | Google Scholar
- Rose PG, Bundy BN, Watkins EB, Thigpen JT and al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999; 340; 15: 1144-1453. PubMed | Google Scholar
- Whitney CW, Sause W, Bundy BN, Maletano JH, Hannigan EV et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. 1999; 17; 5:1339-1348. PubMed | Google Scholar
- Wong LC, Ngan HYS, Cheug ANY, Cheng DKL, Choy DTK. Chemoradiation and adjuvant chemotherapy in cervical cancer. J Clin Oncol. 1999; 17; 7: 2055-60. PubMed | Google Scholar
- Morris M, Eifel PJ, Lu J, Grisby PW, Levenbck C, Stevens RE et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999 Apr 15; 340(15): 1137-43. PubMed | Google Scholar
- Bourhis J, Mornex F. Bases biologiques de la chimioradiothérapie.
In: Mornex F MJ, Droz JP, Marty M, editor. Chimioradiothérapie concomitante
: présent et futur. Paris: Elsevier, 1999. p. 17-27. Google
Scholar
- Robert J. Bases pharmacologiques des associations
radiothérapie-chimiothérapie.:Enjeux et médicaments utilisés. In: Lagrange
JL, Pignol JP, Bensadoun RJ, editors. Optimisation de l'intensité thérapeutique:
les associations radiothérapie-chimiothérapie. Paris: John Libbey Eurotext.
1997; 23-30. Google
Scholar
- Favaudon V, Noel G. Biological basis for concomitant chemoradiotherapy in carcinomas. Bull Cancer. 2005 Dec; 92(12):1027-31. PubMed | Google Scholar
- Seiwert TY, Salama JK, Vokes EE. The concurrent chemoradiation paradigm-general principles. Nat Clin Pract Oncol. 2007 Feb; 4(2):86-100. PubMed | Google Scholar
- Peters WA, Lui PY, Barrett R, Gordon W, Stock R, Berek JF et al. Cisplatin, 5-Fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive therapy in high-risk, early-stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy : report of a phase III inter-group study: San Francisco, CA, USA. 30th annual meeting of the Society of Gynecologic Oncologists. 1999; 102-114. PubMed | Google Scholar
- Keys H, Gibbons SK. Optimal management of locally advanced cervical carcinoma. J Natl Cancer Inst Monogr. 1996; 21:89-92. PubMed | Google Scholar
- Ozsaran Z, Yalman D, Yurut V, Arsas A and al. Radiochemotherapy for patients with locally advanced cervical cancer: early results. Eur J Gynaecol Oncol. 2003; 24(2):191-4. PubMed | Google Scholar